This programme, which is part of the National Cancer Audit Collaborating Centre (NATCAN), focuses on the care that patients receive for metastatic (secondary) breast cancer in England and Wales, in order to support improvement.
We are working with partners across trusts and cancer alliances, including a range of stakeholders such as patients, providers, data stewards, and charities.” NAoMe State of the Nation Report 2025
Supporting improvement
The NAoMe Quality Improvement Plan describes the approach taken across the NATCAN cancer audits to develop improvement goals and performance indicators / metrics, aiming for these to be measurable, actionable and improvable. Further information can be found on the programme website.
Published results
In addition to HQIP-published reports below, published audit results (including dashboards and more reports, where available) can be accessed freely through the audit website. Individual patient level data is not publicly available.
Latest reports
Metastatic breast cancer State of the Nation report 2026
- National Audit of Metastatic Breast Cancer (NAoMe),
- National Cancer Audit Collaborating Centre (NATCAN)
This report reviews care for people with newly diagnosed metastatic breast cancer (MBC) across England...
Metastatic breast cancer report 2025
- National Audit of Metastatic Breast Cancer (NAoMe),
- National Cancer Audit Collaborating Centre (NATCAN)
The National Audit of Metastatic Breast Cancer (NAoMe), part of the National Cancer Audit Collaborating...
Metastatic breast cancer report 2024
- National Audit of Metastatic Breast Cancer (NAoMe),
- National Cancer Audit Collaborating Centre (NATCAN)
The National Audit of Metastatic Breast Cancer (NAoMe), part of the National Cancer Audit Collaborating...